Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

Herz - 1 Mar 2018

Sedaghat-Hamedani F, Katus H A, Meder B

Abstract excerpt

Evidence-based medicine has considerably advanced the treatment of highly prevalent cardiovascular diseases. Its implementation was driven by multicenter interventional trials in treatment and placebo cohorts, propelling numerous biomedical innovations toward standard of care. While a uniform treatment can be effective in such disease cohorts ("one size fits all"), it neglects the genetic and phenotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Products
Share to Cardiomyopathies
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Genotype

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Treatment Outcome

Source

Identifiers

PMID: 29260236
DOI: 10.1007/s00059-017-4667-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.PMID 29260236Read ↗

Precision medicine approach to genetic cardiomyopathy.Semantic proximity Read ↗

Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Semantic proximity Read ↗

Epidemiology and Clinical Aspects of Genetic Cardiomyopathies.Semantic proximity Read ↗

Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.Semantic proximity Read ↗

Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine.Semantic proximity Read ↗

Novel Therapies for Prevention and Early Treatment of CardiomyopathiesSemantic proximity Read ↗

Personalized medicine for cardiovascular diseases.Semantic proximity Read ↗

Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.Semantic proximity Read ↗

[The role of molecular biology in the diagnosis and treatment of cardiovascular diseases].Semantic proximity Read ↗

Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review.Semantic proximity Read ↗

Precision Medicine and Personalized Medicine in Cardiovascular Disease.Semantic proximity Read ↗

Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.